| Literature DB >> 35537792 |
Ai Chee Yong1, Anne Effiom Ebri1, Sara E O'Connor2, Diarmuid O'Donovan1, Nathan Congdon1,3, Christine Graham4, Lynne Lohfeld1,5, Ciaran O'Neill1, Ving Fai Chan6,7.
Abstract
OBJECTIVES: To describe the demographic characteristics and ocular needs of children attending four child eye clinics in Cross River State, Nigeria, to inform the development of a sustainable spectacle cross-subsidisation scheme.Entities:
Keywords: Epidemiology; OPHTHALMOLOGY; PUBLIC HEALTH
Mesh:
Year: 2022 PMID: 35537792 PMCID: PMC9092169 DOI: 10.1136/bmjopen-2021-060379
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 3.006
Shows the spectacle types, description, proposed pricing and profit and loss margins from the spectacle sales
| Spectacle type | Description | Proposed pricing | Profit/loss margin |
| Standard | Limited selection of frames and normal plastic lenses | ₦2500 | 25% loss |
| Mid-premium | Upgraded frames and normal plastic lenses | ₦3600 | 50% profit |
| High premium | Upgraded frames and upgraded lenses | ₦4400 | 50% profit |
Children’s sociodemographic characteristics (n=3774)
| Clinics | Total | P value comparing demographic variables among the four clinics | ||||
| Calabar, | Ugep, | Ikom, | Ogoja, | |||
| Sex | <0.001* | |||||
| Girls | 999 (58.7) | 484 (72.2) | 368 (62.0) | 473 (58.6) | 2324 (61.6) | |
| Boys | 703 (41.3) | 186 (27.8) | 227 (38.0) | 334 (41.4) | 1449 (38.4) | |
| Age groups | <0.001* | |||||
| ≤5 years old | 290 (17.0) | 21 (3.10) | 188 (31.6) | 107 (13.3) | 606 (16.1) | |
| six to 12 years old | 736 (43.2) | 292 (43.6) | 200 (33.7) | 361 (44.7) | 1589 (42.1) | |
| ≥13 years old | 676 (39.7) | 357 (53.3) | 207 (34.7) | 339 (42.0) | 1578 (41.8) | |
| Mean age±SD (years) | 10.4±4.31 | 12.2±2.74 | 9.02±5.38 | 10.9±4.15 | 10.6±4.35 | <0.001† |
| Residence location | <0.001* | |||||
| Rural | 783 (46.0) | 160 (23.9) | 77 (13.0) | 145 (18.0) | 1165 (30.9) | |
| Urban | 919 (54.0) | 510 (76.1) | 518 (87.0) | 662 (82.0) | 2608 (69.1) | |
| History of wearing spectacles | <0.001* | |||||
| No | 1615 (94.9) | 668 (99.7) | 563 (94.8) | 797 (98.8) | 3643 (96.6) | |
| Yes | 87 (5.10) | 2 (0.30) | 32 (5.20) | 10 (1.20) | 130 (3.40) | |
| Total | 1702 (100) | 670 (100) | 595 (100) | 807 (100) | 3774 (100) | |
*χ2 was used, significant level at 5%.
†ANOVA was used.
ANOVA, analysis of variance.
Children’s vision status and diagnosis (n=3773)
| Visual acuity in Snellen in the worse eye | Total | Visual acuity in LEA grating in the worse eye | Total | |||||
| No vision impairment | Vision impairment | 8.0cpcm | 4.0cpcm | ≤3.0cpcm | ||||
| ≥6/12 | <6/12 to 3/60 | <3/60 | ||||||
| Amblyopia | 0 (0.0%) | 5 (0.5%) | 0 (0.0%) | 5 (0.1%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) |
| Cataract | 2 (0.1%) | 15 (1.6%) | 59 (33.3%) | 76 (2.2%) | 3 (1.3%) | 3 (12%) | 1 (5.9%) | 7 (2.6%) |
| Conjunctival disorders | 991 (41.5%) | 59 (6.2%) | 5 (2.8%) | 1055 (30.1%) | 196 (87.1%) | 16 (64%) | 7 (41.2%) | 219 (82.0%) |
| Corneal disorders | 12 (0.5%) | 22 (2.3%) | 25 (14.1%) | 59 (1.7%) | 1 (0.4%) | 3 (12%) | 1 (5.9%) | 5 (1.9%) |
| Eyelid disorders | 28 (1.2%) | 8 (0.8%) | 0 (0.0%) | 36 (1.0%) | 3 (1.3%) | 1 (4.0%) | 0 (0.0%) | 4 (1.5%) |
| Glaucoma | 13 (0.5%) | 4 (0.4%) | 2 (1.1%) | 19 (0.5%) | 0 (0.0%) | 0 (0.0%) | 2 (11.8%) | 2 (0.7%) |
| Lacrimal duct disorders | 10 (0.4%) | 0 (0.0%) | 0 (0.0%) | 10 (0.3%) | 5 (2.0%) | 0 (0.0%) | 0 (0.0%) | 5 (1.9%) |
| Macular disorders | 0 (0.0%) | 3 (0.3%) | 5 (2.8%) | 8 (0.2%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) |
| Nystagmus | 1 (0.0%) | 2 (0.2%) | 0 (0.0%) | 3 (0.1%) | 0 (0.0%) | 0 (0.0%) | 2 (11.8%) | 2 (0.7%) |
| Ocular cancer | 1 (0.0%) | 1 (0.1%) | 3 (1.7%( | 5 (0.1%) | 0 (0.0%) | 0 (0.0%) | 2 (11.8%) | 2 (0.7%) |
| Ocular injury | 34 (1.4%) | 11 (1.2%) | 15 (8.5%) | 60 (1.7%) | 2 (0.9%) | 0 (0.0%) | 0 (0.0%) | 2 (0.7%) |
| Optic nerve disorders | 0 (0.0%) | 0 (0.0%) | 3 (1.7%) | 3 (0.1%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) |
| Refractive error | 1038 (43.5%) | 791 (83.9%) | 36 (20.3%) | 1865 (53.2%) | 2 (0.9%) | 0 (0.0%) | 0 (0.0%) | 2 (0.7%) |
| Retinal disorders | 0 (0.0%) | 3 (0.3%) | 7 (4.0%) | 10 (0.3%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) |
| Routine check | 228 (9.6%) | 3 (0.3%) | 0 (0.0%) | 231 (6.6%) | 10 (3.9%) | 1 (4.0%) | 1 (5.9%) | 12 (4.5%) |
| Sclera disorders | 5 (0.2%) | 0 (0.0%) | 0 (0.0%) | 5 (0.1%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) |
| Strabismus | 4 (0.2%) | 3 (0.3%) | 1 (0.6%) | 8 (0.2%) | 1 (0.4%) | 1 (4.0%) | 1 (5.9%) | 3 (1.1%) |
| Uveitis | 18 (0.7%) | 8 (0.8%) | 5 (2.8%) | 31 (0.9%) | 2 (0.9%) | 0 (0.0%) | 0 (0.0%) | 2 (0.7%) |
| Others | 1 (0.0%) | 5 (0.5%) | 11 (6.2%) | 17 (0.5%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) |
| Total | 2386 (100%) | 943 (100%) | 177 (100%) | 3506 (100%) | 225 (100%) | 25 (100%) | 17 (100%) | 267 (100%) |
Missing data, n=1.
Snellen 6/12 equals to Log of Minimum Angle of Resolution (LogMAR) 0.3; Snellen 3/60 equals to LogMAR 1.3; cpcm=cycles per 1 cm (refer to online supplemental file for ocular disorders categorisation).
Types of management in the four public child eye clinics (n=3774)
| Types of management | Clinics | Total | |||
| Calabar, | Ugep, | Ikom, | Ogoja, | ||
| Counselling | 39 (2.29) | 38 (5.67) | 0 (0.0) | 0 (0.0) | 77 (2.03) |
| Foreign body removal | 1 (0.06) | 0 (0.0) | 1 (0.17) | 1 (0.12) | 3 (0.08) |
| Low vision rehabilitation/devices | 3 (0.18) | 0 (0.0) | 2 (0.34) | 1 (0.12) | 6 (0.16) |
| Medications | 617 (36.3) | 261 (39.0) | 259 (43.6) | 390 (48.3) | 1527 (40.5) |
| Referred for further action* | 84 (4.93) | 2 (0.30) | 16 (2.69) | 20 (2.48) | 122 (3.21) |
| Spectacles | 957 (56.2) | 369 (55.1) | 165 (27.7) | 342 (42.4) | 1833 (48.6) |
| Warm compression | 0 (0.0) | 0 (0.0) | 2 (0.34) | 1 (0.1) | 3 (0.08) |
| None† | 1 (0.06) | 0 (0.0) | 150 (25.2) | 52 (6.44) | 203 (5.40) |
| Total | 1702 (100) | 670 (100) | 595 (100) | 807 (100) | 3774 (100) |
*Eye conditions such as cataract, ocular injury, nystagmus, ocular cancer, retinal disorders, etc.
†Routine follow-up children with no further management.
Children’s characteristics who were prescribed spectacles (n=1833)
| Clinics | Total | P value comparing demographic variables among the four clinics* | P value comparing demographic variables and status of prescribing spectacles* | ||||
| Calabar, | Ugep, | Ikom, | Ogoja, | ||||
| Sex | 0.045 | <0.001 | |||||
| Girls | 654 (68.3) | 266 (72.1) | 113 (68.5) | 213 (62.3) | 1246 (68.0) | ||
| Boys | 303 (31.7) | 103 (27.9) | 52 (31.5) | 129 (37.7) | 587 (32.0) | ||
| Age group | <0.001 | <0.001 | |||||
| ≤5 years old | 45 (4.70) | 0 (0.00) | 4 (2.40) | 8 (2.30) | 57 (3.10) | ||
| 6–12 years old | 421 (44.0) | 143 (38.8) | 68 (41.2) | 162 (47.4) | 794 (43.3) | ||
| ≥13 years old | 491 (51.3) | 226 (61.2) | 93 (56.4) | 172 (50.3) | 982 (53.6) | ||
| Children’s location | <0.001 | 0.204 | |||||
| Rural | 432 (45.1) | 83 (22.5) | 19 (11.5) | 50 (14.6) | 584 (31.9) | ||
| Urban | 525 (54.9) | 286 (77.5) | 146 (88.5) | 292 (85.4) | 1249 (68.1) | ||
| History of wearing spectacles | <0.001 | <0.001 | |||||
| No | 878 (91.7) | 368 (99.7) | 139 (84.2) | 332 (97.1) | 1717 (93.7) | ||
| Yes | 79 (8.30) | 1 (0.30) | 26 (15.8) | 10 (2.90) | 116 (6.30) | ||
| Spherical equivalent† | <0.001 | <0.001 | |||||
| >−6.00DS | 19 (2.00) | 2 (0.54) | 1 (0.60) | 5 (1.45) | 27 (1.46) | ||
| >−3.00 DS to −6.00DS | 71 (7.40) | 6 (1.61) | 6 (3.59) | 13 (3.76) | 96 (5.20) | ||
| >−0.25 DS to −3.00DS | 285 (29.8) | 300 (81.3) | 80 (48.5) | 62 (18.1) | 727 (39.7) | ||
| <−0.50 DS to+1.75DS | 565 (59.0) | 59 (15.9) | 72 (43.1) | 249 (72.8) | 945 (51.6) | ||
| >+1.75 DS to+5.00DS | 14 (1.50) | 1 (0.30) | 4 (2.40) | 12 (3.50) | 31 (1.73) | ||
| >+5.00DS | 3 (0.30) | 1 (0.30) | 2 (1.20) | 1 (0.29) | 7 (0.38) | ||
| Total | 957 (100) | 369 (100) | 165 (100) | 342 (100) | 1833 (100) | ||
*χ2 test was used, significant level at 5%.
†Spherical equivalent was calculated by adding half of the cylindrical power to the spherical power.
Figure 1Proposed spectacle cross-subsidisation strategy.